22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net profit of CHF 12.1 millionStrengthened balance sheet through non-dilutive repayment of
Press Release Basel, Switzerland, April 13, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the board of directors at today's annual general
Investegate announcements from Basilea Pharmaceutica AG, Basilea shareholders approve all proposals of the board of directors at the annual general meeting
Notice To Attend The Annual General Meeting Of Shareholders pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
GOTHENBURG, SWEDEN / ACCESSWIRE / April 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)The shareholders of IRLAB Therapeutics AB, company registration no. 556931-4692 ("IRLAB" or the "Company")